FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
11,723 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Adaptopathadenosinum cyclophosphoricum, alpha-lipoicum acidum, argentum metallicum, avena sativa, capsicum annuum, citricum acidum, coenzyme a, cuprum metallicum, ginkgo biloba, glandula suprarenalis suis, glycyrrhiza glabra, hypothalamus (bovine), iodium, ledum palustre, manganum aceticum, nadidum, natrum carbonicum, oleum morrhuae, phosphoricum acidum, picricum acidum, riboflavinum, selenium metallicum sepia, silicea, thiaminum hydrochloricum, thyroidinum (bovine), vanadium metallicum | Adenosine cyclic phosphate 8 [hp_X]/mL + 26 more ingredients | LiquidOral | Energetix Corporation | Unapproved homeopathic | 64578-0095 | 64578-0095-01 | — |
| Adasuveloxapine |
|---|
| Loxapine 10 mg/1 |
| Aerosol, PowderRespiratory (Inhalation) |
| Alexza Pharmaceuticals, Inc. |
| NDA |
| 51097-001 |
| 51097-0001-02 |
| — |
| Adbrytralokinumab-ldrm | Tralokinumab 150 mg/mL | Injection, SolutionSubcutaneous | LEO Pharma Inc. | BLA | 50222-346 | 50222-0346-0250222-0346-0450222-0346-92 | — |
|---|
| Adbrytralokinumab-ldrm | Tralokinumab 300 mg/2mL | Injection, SolutionSubcutaneous | LEO Pharma Inc. | BLA | 50222-350 | 50222-0350-0150222-0350-0250222-0350-91 | — |
|---|
| Adcetrisbrentuximab vedotin | Brentuximab vedotin 50 mg/10.5mL | Injection, Powder, Lyophilized, For solutionIntravenous | SEAGEN INC. | BLA | 51144-050 | 51144-0050-01 | — |
|---|
| Adcircatadalafil | Tadalafil 20 mg/1 | TabletOral | United Therapeutics Corporation | NDA | 66302-467 | 66302-0467-60 | — |
|---|
| Adderalldextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 1.25 mg/1 + 3 more ingredients | TabletOral | Teva Pharmaceuticals USA, Inc. | ANDA | 57844-105 | 57844-0105-01 | — |
|---|
| Adderalldextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 2.5 mg/1 + 3 more ingredients | TabletOral | Teva Pharmaceuticals USA, Inc. | ANDA | 57844-110 | 57844-0110-01 | — |
|---|
| Adderalldextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 3.125 mg/1 + 3 more ingredients | TabletOral | Teva Pharmaceuticals USA, Inc. | ANDA | 57844-112 | 57844-0112-01 | — |
|---|
| Adderalldextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 3.75 mg/1 + 3 more ingredients | TabletOral | Teva Pharmaceuticals USA, Inc. | ANDA | 57844-115 | 57844-0115-01 | — |
|---|
| Adderalldextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 1.875 mg/1 + 3 more ingredients | TabletOral | Teva Pharmaceuticals USA, Inc. | ANDA | 57844-117 | 57844-0117-01 | — |
|---|
| Adderalldextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 5 mg/1 + 3 more ingredients | TabletOral | Teva Pharmaceuticals USA, Inc. | ANDA | 57844-120 | 57844-0120-01 | — |
|---|
| Adderalldextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate | Dextroamphetamine saccharate 7.5 mg/1 + 3 more ingredients | TabletOral | Teva Pharmaceuticals USA, Inc. | ANDA | 57844-130 | 57844-0130-01 | — |
|---|
| Adderall XRdextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate | Dextroamphetamine sulfate 1.25 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-381 | 54092-0381-01 | — |
|---|
| Adderall XRdextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate | Dextroamphetamine sulfate 2.5 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-383 | 54092-0383-01 | — |
|---|
| Adderall XRdextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate | Dextroamphetamine sulfate 3.75 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-385 | 54092-0385-01 | — |
|---|
| Adderall XRdextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate | Dextroamphetamine sulfate 5 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-387 | 54092-0387-01 | — |
|---|
| Adderall XRdextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate | Dextroamphetamine sulfate 6.25 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-389 | 54092-0389-01 | — |
|---|
| Adderall XRdextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate | Dextroamphetamine sulfate 7.5 mg/1 + 3 more ingredients | Capsule, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-391 | 54092-0391-01 | — |
|---|
| Addexlappa major, plantago major, taraxacum officinale, glyphosate | Arctium lappa root 3 [hp_X]/mL + 3 more ingredients | SprayOral | Nutritional Specialties, Inc. | Unapproved homeopathic | 83027-0044 | 83027-0044-01 | — |
|---|
| Addiclenzbeta vulgaris, boldo, chelidonium majus, petroselinum sativum, taraxacum officinale, arsenicum album, bisphenol a, cobaltum metallicum, cuprum metallicum, glyphosate, iodium, lycopodium clavatum, phosphoricum acidum, selenium metallicum, zincum metallicum, aspartame, benzalkonium chloride, formalinum, methylene chloride, methyl paraben, propyl paraben, sodium benzoate, sodium citrate, titanium dioxide, zincum oxydatum | Beta vulgaris 3 [hp_X]/mL + 24 more ingredients | LiquidOral | Deseret Biologicals, Inc. | Unapproved homeopathic | 43742-1558 | 43742-1558-01 | — |
|---|
| Addiclenzboldo, carduus marianus, chelidonium majus, petroselinum sativum, taraxacum officinale, arsenicum album, bisphenol a, cobaltum metallicum, cuprum metallicum, glyphosate, iodium, lycopodium clavatum, phosphoricum acidum, selenium metallicum, zincum metallicum, aspartame, benzalkonium chloride, formalinum, methylene chloride, methyl paraben, propyl paraben, sodium benzoate, sodium citrate, titanium dioxide, zincum oxydatum | Peumus boldus leaf 3 [hp_X]/mL + 24 more ingredients | LiquidOral | Deseret Biologicals, Inc. | Unapproved homeopathic | 43742-2055 | 43742-2055-01 | — |
|---|
| Addiclenzaspartame, benzalkonium chloride, formalinum, methylene chloride, methylparaben, propylparaben, sodium benzoate, sodium citrate, titanium dioxide, zincum oxydatum, arsenicum album, beta vulgaris, bisphenol a, boldo, chelidonium majus, cobaltum metallicum, cuprum metallicum, glyphosate, iodium, lycopodium clavatum, petroselinum sativum, phosphoricum acidum, selenium metallicum, taraxacum officinale, zincum metallicum | Aspartame 30 [hp_X]/mL + 24 more ingredients | LiquidOral | Deseret Biologicals, Inc. | Unapproved homeopathic | 43742-2261 | 43742-2261-01 | — |
|---|
| Additive Formula 3dextrose monohydrate, trisodium citrate dihydrate, sodium chloride, sodium phosphate, monobasic, monohydrate, citric acid monohydrate, and adenine | Dextrose monohydrate 1.1 g/100mL + 5 more ingredients | SolutionIntravenous | Terumo BCT, Ltd | NDA | 14537-832 | 14537-0832-03 | — |
|---|
| Additive Formula 3dextrose monohydrate, trisodium citrate dihydrate, sodium chloride, sodium phosphate, monobasic, monohydrate, citric acid monohydrate, and adenine | Dextrose monohydrate 1.1 g/100mL + 5 more ingredients | SolutionIntravenous | Terumo BCT, Ltd | NDA | 14537-833 | 14537-0833-03 | — |
|---|
| Additivestattrifolium pratense, petroleum, phytolacca decandra, arsenicum album, chelidonium majus, lycopodium clavatum, nux vomica, phosphoricum acidum, phosphorus, nitricum acidum | Trifolium pratense flower 3 [hp_X]/mL + 9 more ingredients | LiquidOral | Energique, Inc. | Unapproved homeopathic | 44911-0630 | 44911-0630-01 | — |
|---|
| Additoxtrifolium pratense, xanthoxylum fraxineum, phytolacca decandra, arsenicum album, belladonna, chelidonium majus, lycopodium clavatum, phosphoricum acidum, aspartame, benzalkonium chloride, formalinum, methylene chloride, methylparaben, propylparaben, sodium benzoate, sodium citrate, titanium dioxide, zincum oxydatum | Trifolium pratense flower 3 [hp_X]/mL + 17 more ingredients | LiquidOral | BioActive Nutritional, Inc. | Unapproved homeopathic | 43857-0487 | 43857-0487-01 | — |
|---|
| Addyiflibanserin | Flibanserin 100 mg/1 | Tablet, Film coatedOral | Sprout Pharmaceuticals, Inc. | NDA | 58604-214 | 58604-0214-30 | — |
|---|
| Adefovir Dipivoxil | Adefovir dipivoxil 10 mg/1 | TabletOral | Sigmapharm Laboratories, LLC | ANDA | 42794-003 | 42794-0003-08 | — |
|---|
| Adefovir dipivoxil | Adefovir dipivoxil 10 mg/1 | TabletOral | Apotex Corp. | ANDA | 60505-3947 | 60505-3947-03 | — |
|---|
| Adellina Lidocaine Numbing Cream Anorectal(Hemorrhoidal) Creamlidocaine | Lidocaine 5 g/100g | CreamTopical | Guangzhou Haishi Biological Technology Co., Ltd. | OTC monograph drug | 60771-0041 | 60771-0041-01 | — |
|---|
| Adellina Lidocaine Numbing Cream Topical Anorectal Creamlidocaine | Lidocaine 5 g/100g | CreamTopical | Guangdong Aimu Biological Technology Co., Ltd | OTC monograph drug | 83566-612 | 83566-0612-02 | — |
|---|
| Adellina Lidocaine Numbing Cream Topical Anorectal Creamlidocaine | Lidocaine 5 g/100g | CreamTopical | Guangdong Aimu Biological Technology Co., Ltd | OTC monograph drug | 83566-614 | 83566-0614-01 | — |
|---|
| Adellina Numbing Creamlidocaine | Lidocaine 5 g/100mL | CreamTopical | Guangzhou Haishi Biological Technology Co., Ltd. | OTC monograph drug | 60771-0011 | 60771-0011-01 | — |
|---|
| Adempasriociguat | Riociguat .5 mg/1 | Tablet, Film coatedOral | Bayer HealthCare Pharmaceuticals Inc. | NDA | 50419-250 | 50419-0250-0150419-0250-0350419-0250-71+1 more | — |
|---|
| Adempasriociguat | Riociguat 1 mg/1 | Tablet, Film coatedOral | Bayer HealthCare Pharmaceuticals Inc. | NDA | 50419-251 | 50419-0251-0150419-0251-0350419-0251-71+1 more | — |
|---|
| Adempasriociguat | Riociguat 1.5 mg/1 | Tablet, Film coatedOral | Bayer HealthCare Pharmaceuticals Inc. | NDA | 50419-252 | 50419-0252-0150419-0252-0350419-0252-91 | — |
|---|
| Adempasriociguat | Riociguat 2 mg/1 | Tablet, Film coatedOral | Bayer HealthCare Pharmaceuticals Inc. | NDA | 50419-253 | 50419-0253-0150419-0253-0350419-0253-91 | — |
|---|
| Adempasriociguat | Riociguat 2.5 mg/1 | Tablet, Film coatedOral | Bayer HealthCare Pharmaceuticals Inc. | NDA | 50419-254 | 50419-0254-0150419-0254-0350419-0254-91 | — |
|---|
| Adenine 1546adenine | Adenine 9 [hp_X]/29.5mL | LiquidOral | Professional Complementary Health Formulas | Unapproved homeopathic | 63083-1546 | 63083-1546-01 | — |
|---|
| Adenine 3X | Adenine 3 [hp_X]/mL | LiquidOral | Energique, Inc. | Unapproved homeopathic | 44911-0745 | 44911-0745-01 | — |
|---|
| Adenosineadenosine injection, solution | Adenosine 3 mg/mL | Injection, SolutionIntravenous | Henry Schein, Inc. | ANDA | 0404-9993 | 00404-9993-02 | — |
|---|
| Adenosine | Adenosine 3 mg/mL | Injection, SolutionIntravenous | NorthStar Rx LLC | ANDA | 16714-556 | 16714-0556-01 | — |
|---|
| Adenosine | Adenosine 3 mg/mL | Injection, SolutionIntravenous | NorthStar Rx LLC | ANDA | 16714-997 | 16714-0997-01 | — |
|---|
| Adenosine | Adenosine 3 mg/mL | Injection, SolutionIntravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-258 | 23155-0258-3123155-0258-3223155-0258-41+1 more | — |
|---|
| adenosine | Adenosine 3 mg/mL | InjectionIntravenous | Sagent Pharmaceuticals | ANDA | 25021-301 | 25021-0301-6725021-0301-68 | — |
|---|
| Adenosine | Adenosine 3 mg/mL | InjectionIntravenous | Sagent Pharmaceuticals | ANDA | 25021-318 | 25021-0318-0225021-0318-04 | — |
|---|
| Adenosine | Adenosine 3 mg/mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1450 | 51662-1450-03 | — |
|---|
| Adenosine | Adenosine 3 mg/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1511 | 51662-1511-01 | — |
|---|
| Adenosine | Adenosine 3 mg/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1631 | 51662-1631-01 | — |
|---|